CRISPR Therapeutics AG (CRSP) Capital Expenditures (2015 - 2026)
CRISPR Therapeutics AG (CRSP) reported Capital Expenditures of $648,000 for Q2 2026, up 453.8% from $117,000 a year earlier and up 28.6% from the prior quarter.
Powered by 
Analysis
CRISPR Therapeutics AG (CRSP) Capital Expenditures (2015 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, CRISPR Therapeutics AG's Capital Expenditures came in at $1.74 million, up 119.0% year-over-year; for FY2025, it was $914,000, down 51.9% from FY2024.
- Capital Expenditures has declined for four consecutive years, with a five-year compound annual growth rate of -45.1% (FY2020 to FY2025).
- By year, Capital Expenditures came in at $1.9 million in FY2024 (-79.9%), $9.47 million in FY2023 (-74.5%), $37.19 million in FY2022 (-54.5%) and $81.71 million in FY2021 (+345.1%).
- The Q2 2026 figure ranks as the highest quarterly Capital Expenditures since Q2 2024.
- Year over year, Capital Expenditures has now increased in each of the last three quarters, with growth averaging 40.7% over the last eight quarters.
- The high point for year-over-year Capital Expenditures in five years was Q3 2021 (growth of 570.8%); the low point was Q3 2024 (a decline of 89.7%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $504,000 (Q1 2026), $517,000 (Q4 2025) and $74,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 1.32 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 322.00 Mn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 893.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -321.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -763.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 513.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 140.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 533.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 112.20 Mn |
| 10 | CRISPR Therapeutics AG | 5.35 Bn | 5.35 Bn | - | 648,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 648,000.00 |
| Mar 31, 2026 | 504,000.00 |
| Dec 31, 2025 | 517,000.00 |
| Sep 30, 2025 | 74,000.00 |
| Jun 30, 2025 | 117,000.00 |
| Mar 31, 2025 | 206,000.00 |
| Dec 31, 2024 | 254,000.00 |
| Sep 30, 2024 | 219,000.00 |
| Jun 30, 2024 | 707,000.00 |
| Mar 31, 2024 | 721,000.00 |
| Dec 31, 2023 | 738,000.00 |
| Sep 30, 2023 | 2.12 Mn |
| Jun 30, 2023 | 3.56 Mn |
| Mar 31, 2023 | 3.06 Mn |
| Dec 31, 2022 | 6.19 Mn |
| Sep 30, 2022 | 6.02 Mn |
| Jun 30, 2022 | 9.63 Mn |
| Mar 31, 2022 | 15.35 Mn |
| Dec 31, 2021 | 9.18 Mn |
| Sep 30, 2021 | 37.05 Mn |
API Access
CRISPR Therapeutics AG Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=CRSP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "CRSP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=CRSP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();